CAMBREX PROFARMACO MILANO SRL

Overview

CAMBREX PROFARMACO MILANO SRL is an active pharmaceutical ingredient (API) supplier with 47 active FDA Type II Drug Master Files, covering ALBUTEROL / SALBUTAMOL SULPHATE; ALPRAZOLAM; AMIODARONE HCL; BISACODYL; CHLORDIAZEPOXIDE; CHLORDIAZEPOXIDE HYDROCHLORIDE.

API / Drug Master Files

CAMBREX PROFARMACO MILANO SRL holds 47 active (67 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MIRABEGRONActive2026-02-27
• DAPAGLIFLOZIN PROPYLENE GLYCOL MONOHYDRATEActive2025-07-23
• ELTROMBOPAG OLAMINEActive2024-07-25
• MIDAZOLAM HYDROCHLORIDEActive2024-06-11
• OLAPARIBActive2024-02-09
• MIDAZOLAM MALEATEActive2022-06-10
• MARAVIROCActive2020-11-18
• RIFAXIMINActive2016-11-04
• LACOSAMIDEActive2015-09-07
• CLOBAZAMActive2015-01-27
• EPINEPHRINE BITARTRATEActive2014-06-03
• CYSTEAMINE BITARTRATE (RP)Active2013-07-25
• EPINEPHRINEActive2012-04-13
• SODIUM PICOSULFATEActive2010-01-18
• RALOXIFENE HYDROCHLORIDEActive2009-07-07

Showing 15 of 67 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CAMBREX PROFARMACO MILANO SRL in our records. PharmaTek screens the full directory against live FDA enforcement data.